Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter, Double-blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

NCT03039699 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03039699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03039699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter, Double-blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
June 23, 2016
Completion date
June 1, 2019
Enrollment
259 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

viral intestinal infection